Insiders Eli Lilly and Company Xetra

Equities

Real-time Estimate Tradegate Other stock markets 10:28:22 2024-07-17 EDT			5-day change	1st Jan Change
835.6 ^EUR	-4.20%		-4.31%	+57.69%

03:53pm	TD Cowen Raises Price Target on Eli Lilly to $1,050 From $850	MT
03:38pm	Earnings reports take center stage as tech stocks tumble

Eli Lilly Names Gordon Brooks Interim Chief Financial Officer	07-10	DJ
Eli Lilly Appoints Gordon Brooks Interim CFO	07-10	MT
Eli Lilly Names Gordon Brooks Interim CFO	07-10	MT
Eli Lilly and Company Announces Chief Financial Officer Changes	07-10	CI
Eli Lilly and Company Announces Resignation of Anat Ashkenazi Resigned as Executive Vice President	07-10	CI
VYNE Therapeutics Inc. Announces Appointment of Subhashis Banerjee, M.D. as Senior Vice President of Clinical Development	07-09	CI
A weight loss ETF	06-18	MT
Alzheon, Inc Announces Appointment of Gino Santini to Board of Directors	06-12	CI
Alphabet Appoints Anat Ashkenazi as CFO	06-05	MT
Eli Lilly's CFO Anat Ashkenazi Resigns	06-05	MT
Eli Lilly CFO Anat Ashkenazi Resigns	06-05	MT
Correction to Alphabet CFO Article	06-05	DJ
Google Poaches Eli Lilly Finance Chief Ashkenazi -- Update	06-05	DJ
Alphabet: Eli Lilly CFO recruited	06-05	CF
Google Poaches Eli Lilly Finance Chief Ashkenazi	06-05	DJ
Eli Lilly Chief Financial Officer Anat Ashkenazi Leaving	06-05	DJ
Alphabet names Eli Lilly executive Anat Ashkenazi as CFO	06-05	RE
Eli Lilly finance chief to leave company	06-05	RE
Eli Lilly and Company Announces Resignation of Anat Ashkenazi as Executive Vice President	06-05	CI
Eli Lilly and Company Announces Resignation of Anat Ashkenazi as Chief Financial Officer, Effective July 2024	06-05	CI

No results for this search

David Ricks, CEO of Eli Lilly: A market of over a billion people

March 12, 2024 at 02:47 pm